International prescribing practices in obsessive-compulsive disorder (OCD).

Area of Science:

• Psychiatry
• Pharmacology
• Global Health

Background:

• Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
• Psychotropic medications are a cornerstone of OCD treatment.
• International variations in treatment practices may affect patient outcomes.

Purpose of the Study:

• To assess the global rates of psychotropic medication use in patients diagnosed with OCD.
• To compare observed medication use patterns with established international treatment guidelines.

Main Methods:

• A multi-center study involving researchers from seven countries across five continents.
• Collection and analysis of summary statistics on patient characteristics and psychotropic medication incidence.
• Evaluation of the consistency of these statistics across participating countries.

Main Results:

• A total of 3139 patients with OCD were included from Brazil, Italy, South Africa, Japan, Australia, India, and Spain.
• The majority of patients (77.9%) received psychotropic medication.
• Selective serotonin reuptake inhibitors (SSRIs) were the most frequently used (73.5%), with usage rates ranging from 59% (Australia) to 96% (Japan). Clomipramine and atypical antipsychotic use also showed significant international variation.

Conclusions:

• Significant international variations in pharmacotherapy for OCD were observed.
• Further prospective research is needed to explore cultural, pharmacoeconomic, and pharmacogenomic factors influencing prescribing practices and treatment outcomes.